GPR39 and colonic neoplasm: In colon cancer cell lines, the activation of the ZnR/GPR39-dependent MAPK and PI3K pathways increases the expression of anti-apoptotic proteins (such as clusterin), thus, attenuating butyric acid-induced apoptosis [62].